International Biotechnology (LON:IBT) Releases Quarterly Earnings Results

International Biotechnology (LON:IBT) issued its earnings results on Tuesday. The company reported GBX (4.83) earnings per share for the quarter, Digital Look Earnings reports. The company had revenue of GBX 24 million during the quarter. International Biotechnology had a negative return on equity of 0.45% and a negative net margin of 6.26%.

International Biotechnology Price Performance

IBT traded down GBX 18 on Tuesday, reaching GBX 972. The company’s stock had a trading volume of 19,538 shares, compared to its average volume of 59,890. The business’s 50 day moving average is GBX 931.35 and its 200 day moving average is GBX 928.16. International Biotechnology has a 1 year low of GBX 546 and a 1 year high of GBX 1,010. The stock has a market cap of £309.37 million, a price-to-earnings ratio of -295.44 and a beta of 0.49.

About International Biotechnology

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.